Literature DB >> 10233996

Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3).

D Hammache1, N Yahi, M Maresca, G Piéroni, J Fantini.   

Abstract

Glycosphingolipids from human erythrocytes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins. To identify the glycosphingolipid(s) which participates in the fusion process, we have analyzed the interaction of HIV-1 gp120 (X4 and R5X4 isolates) with reconstituted membrane microdomains of human erythrocyte glycosphingolipids. We identified globotriaosylceramide (Gb3) and ganglioside GM3 as the main glycosphingolipids recognized by gp120. In the presence of CD4, Gb3 interacted preferentially with the X4 gp120, whereas GM3 interacted exclusively with the R5X4 gp120. These data suggest that glycosphingolipid microdomains are required in CD4-dependent fusion and that Gb3 and/or GM3 may function as alternative entry cofactors for selected HIV-1 isolates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233996      PMCID: PMC112578     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

2.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

3.  Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins.

Authors:  A Puri; S J Morris; P Jones; M Ryan; R Blumenthal
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

Review 4.  Virus receptors: binding, adhesion strengthening, and changes in viral structure.

Authors:  A M Haywood
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells.

Authors:  S L Tamma; S K Sundaram; M Lev; R F Coico
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

6.  The glycosphingolipid composition of the human hepatoma cell line,Hep-G2.

Authors:  P F Spitalnik; J M Danley; S R Burger; S L Spitalnik
Journal:  Arch Biochem Biophys       Date:  1989-09       Impact factor: 4.013

7.  The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

Authors:  A Puri; P Hug; K Jernigan; J Barchi; H Y Kim; J Hamilton; J Wiels; G J Murray; R O Brady; R Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Surface behaviour of gangliosides and related glycosphingolipids.

Authors:  B Maggio; F A Cumar; R Caputto
Journal:  Biochem J       Date:  1978-06-01       Impact factor: 3.857

9.  Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  T Dragic; L Picard; M Alizon
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content.

Authors:  A Pellizzari; H Pang; C A Lingwood
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

View more
  45 in total

1.  Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.

Authors:  S Mañes; G del Real; R A Lacalle; P Lucas; C Gómez-Moutón; S Sánchez-Palomino; R Delgado; J Alcamí; E Mira; C Martínez-A
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

Review 2.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion.

Authors:  Satinder S Rawat; Christina Zimmerman; Benitra T Johnson; Edward Cho; Stephen J Lockett; Robert Blumenthal; Anu Puri
Journal:  Mol Membr Biol       Date:  2008-01       Impact factor: 2.857

Review 4.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

5.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 6.  Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Authors:  Wendy Blay Puryear; Suryaram Gummuluru
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Authors:  Richard D Kensinger; Bradley J Catalone; Fred C Krebs; Brian Wigdahl; Cara-Lynne Schengrund
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 8.  Lipids and membrane microdomains in HIV-1 replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Virus Res       Date:  2009-04-19       Impact factor: 3.303

9.  The Role of Lipids in Retrovirus Replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

10.  Human erythrocytes selectively bind and enrich infectious HIV-1 virions.

Authors:  Zoltan Beck; Bruce K Brown; Lindsay Wieczorek; Kristina K Peachman; Gary R Matyas; Victoria R Polonis; Mangala Rao; Carl R Alving
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.